Key result
Combined therapy with IV methylprednisolone, enoxaparin, colchicine, and infliximab achieved clinical remission and resolution of CMR late gadolinium enhancement within 6 months.
Why the study?
Cardiac involvement such as myopericarditis and intracavitary thrombosis is a rarely described extraintestinal complication of ulcerative colitis that poses a diagnostic challenge and requires specialised imaging for confirmation and timely management.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
This case report highlights that concurrent myopericarditis and right atrial thrombus can present as rare, life-threatening extraintestinal manifestations of an acute ulcerative colitis flare, requiring cardiac MRI for diagnosis and combined anticoagulation and anti-inflammatory/biologic therapy for resolution.
Ulcerative colitis (UC) is a chronic inflammatory bowel disease with a systemic nature, primarily affecting the rectum and colon. However, it can also manifest with extraintestinal symptoms. In rare cases, there may be cardiac involvement, such as myopericarditis, which is a rarely described complication. The diagnosis of this condition poses a clinical challenge and requires specialised imaging studies for confirmation and timely management. A 26-year-old female with a 5-year history of ulcerative colitis presented with a severe relapse, characterised by bloody diarrhoea, weight loss, abdominal and chest pain, as well as joint symptoms. During the patient’s hospitalisation, she developed hypotension, fever, and elevated high-sensitivity cardiac troponin I (1.078 ng/L). Cardiac magnetic resonance (CMR) findings were highly suggestive of myopericarditis, demonstrating myocardial oedema on T2-weighted imaging and non-ischaemic late gadolinium enhancement, fulfilling two Lake Louise criteria. A mobile right atrial mass (22 × 12 mm), consistent with thrombus, was also identified. The patient was successfully treated with intravenous methylprednisolone, enoxaparin, colchicine, and infliximab. This case illustrates a rare extraintestinal manifestation and highlights the importance of considering cardiac complications in patients with inflammatory bowel disease (IBD). The potential roles of systemic inflammation and medication-related adverse effects in the aetiology of this complication are discussed. Myopericarditis and intracavitary thrombosis represent rare but severe extraintestinal manifestations of UC. Clinical suspicion and advanced imaging such as cardiac magnetic resonance are essential for timely diagnosis and management.
No takes yet. Share an insight, caveat, or question.
Dorado-Delgado et al. (2026) conducted a case report in Severe acute ulcerative colitis complicated by myopericarditis and right atrial intracavitary thrombus (n=1). Intravenous methylprednisolone, subcutaneous enoxaparin, colchicine, and infliximab was evaluated on Clinical remission and resolution of myopericarditis and intracavitary thrombus on follow-up cardiac MRI. Combined therapy with IV methylprednisolone, enoxaparin, colchicine, and infliximab achieved clinical remission and resolution of CMR late gadolinium enhancement within 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: